X
Innate Pharma gains rights to AZ’s recently approved leukaemia drug
https://pharmaphorum.com/news/innate-pharma-gains-rights-to-azs-recently-approved-leukaemia-drug/
Innate Pharma
Future uncertain for Innate and BMS’ troubled lirilumab
Doubts over future of cancer immunotherapy
Innate and BMS’ immunotherapy fails in phase 2 trial
French biotech developing cancer immunotherapy with BMS.
Some good news for BMS with Opdivo + natural killer cell combination
But BMS dumps combination with Yervoy.
